REPORT DESCRIPTION
Budesonide Inhaler Market – Taxonomy
The global demand for budesonide inhaler is expected to witness substantial growth over the forecast
period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report
2018, asthma causes around 1000 deaths every day and affects as many as 339 million people worldwide.
However, product recalls due to failure to meet regulatory guidelines is expected to hinder the market
growth. For instance, in 2014, AstraZeneca’s PULMICORT RESPULES (budesonide inhalation
suspension) was recalled by the U.S. FDA as budesonide may be above or below the specification range,
which can be harmful for the patients.
Download PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2551